When was repatha approved by the fda?

When did FDA approve Repatha (evolocumab)?

Repatha (evolocumab) was approved by the U.S. Food and Drug Administration (FDA) on August 27, 2015. [1]

Was the approval for all uses at the same time?

Repatha’s initial FDA approval (August 2015) covered the original indicated patient populations at that time; the label has expanded over subsequent updates through later FDA approvals. [1]

Source

[1] https://www.drugpatentwatch.com/p/repatha-evolocumab/